JF
MREO

Jump Financial’s Mereo BioPharma MREO Stock Holding History

Jump Financial’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,116
Closed -$38.9K – 1862
2024
Q4 		$38.9K Buy
+11,116
New +$43.7K ﹤0.01% 1571
2024
Q2 		– Sell
-126,500
Closed -$417K – 2089
2024
Q1 		$417K Buy
+126,500
New +$428K 0.01% 1281
2021
Q4 		– Sell
-32,788
Closed -$79K – 1597
2021
Q3 		$79K Sell
32,788
-118,912
-78% -$315K 0.01% 998
2021
Q2 		$481K Buy
+151,700
New +$509K 0.05% 490

Other funds holding MREO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Jump Financial's MREO Position: Q1 2025 in Review

Jump Financial sold out of Mereo BioPharma (MREO) in Q1 2025, closing a stake of 11,116 shares — an estimated $38.9K sold.

Jump Financial first reported a position in MREO in Q2 2021 and held it in 4 quarters. The position peaked at $481K in Q2 2021. 90 funds tracked by Wall St. Rank hold MREO as of Q1 2025.

  • Jump Financial reported no remaining Mereo BioPharma position as of Q1 2025 after selling out during the quarter.
  • Jump Financial sold 11,116 Mereo BioPharma shares in Q1 2025, an estimated $38.9K.
  • Jump Financial first reported a position in Mereo BioPharma in Q2 2021 and held it in 4 quarters.
  • Jump Financial's Mereo BioPharma position peaked at $481K in Q2 2021.
  • 90 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2025.

Based on Jump Financial's 13F filing for Q1 2025, filed 14 May 2025.